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Abstract
Background. Bacterial infection remains a major cause of
morbidity and mortality in peritoneal dialysis (PD) patients
worldwide. Previous studies have identiﬁed a key role for
mesothelial cells, lining the peritoneal cavity, in coordinat-
ing inﬂammation and host defense. Toll-like receptor
(TLR) involvement in early activation events within the
mesothelium, however, remains poorly deﬁned. To inves-
tigate the initiation of bacterial peritonitis, we characterized
TLR activation by bacterial ligands in human peritoneal
mesothelial cells (HPMC).
Methods. Primary HPMC were isolated from omental
biopsies and TLR expression detected by real-time polymer-
ase chain reaction (PCR), reverse transcription (RT)–PCR
and ﬂow cytometry. The responsiveness of HPMC to speciﬁc
bacterial TLR agonists was determinedusing chemokine pro-
duction as a biological readout. The requirement for CD14 in
HPMC responses to a clinically relevant Staphylococcus
epidermidis cell-free supernatant (SES) was investigated
using soluble CD14 or anti-CD14-blocking antibodies.
Results. Real-time PCR detected TLR1-6 messenger RNA
expression in HPMC and responses to TLR2/1 and TLR2/6
ligands and SES. No cell surface TLR4 expression or
responses to lipopolysaccharide were detectable in HPMC,
but they did respond to ﬂagellin, a TLR5 ligand. SES-
mediated responses were dependent on TLR2 but did not
require CD14 in HPMC for optimal efﬁciency, unlike
peripheral blood mononuclear cells. HPMC expression of
TLR2 was also modulated by TLR2 ligands and inﬂamma-
tory cytokines.
Conclusions. These data suggest that mesothelial cell acti-
vation by TLR2/1, TLR2/6 and TLR5 contributes to bac-
terial recognition inﬂuencing the course of the infective
process and has implications for improving treatment of
infection in PD patients.
Keywords: bacterial infection; human peritoneal mesothelial cells;
peritonitis; peritoneal dialysis; Toll-like receptors
Introduction
Bacterial peritonitis is a feature of long-term peritoneal
dialysis (PD) and a major cause of impaired peritoneal
function and treatment failure. It is generally accepted that
diminished peritoneal function is in part related to infec-
tion/inﬂammation-driven structural changes within the
membrane including mesothelial cell loss, sub-mesothelial
compact zone thickening and degenerative vascular
changes [1]. Traditionally, PD-associated peritonitis is
related to Gram-positive Staphylococcal species with
Staphylococcus epidermidis and Staphylococcus aureus
found in ~30 to 50% of cases [2]. Clinically severe infec-
tions with Gram-negative bacteria have become more fre-
quent over the past decade, resulting in increased treatment
failure and worse patient outcomes [3]. Previous studies by
our group and others have identiﬁed a central role for the
mesothelial cell in orchestrating peritoneal responses
during inﬂammation and infection [4–7]. Human peritoneal
mesothelial cells (HPMC) are activated by various stimuli,
including bacteria, and regulate leucocyte recruitment
through cytokines and chemokine secretion and adhesion
molecule expression [8–11]. The ability of human meso-
thelial cells to respond directly to bacterial challenge has
been previously suggested, but their responses to bacterial
ligands mediated by the Toll-like receptor family have not
been fully characterized [12].
Toll-like receptors (TLR) play a critical role in innate
immune responses by speciﬁcally recognizing molecular
patterns from a range of microorganisms, including bacte-
ria, fungi and viruses [13]. TLR4 was initially identiﬁed as
the TLR responsible for Gram-negative bacteria-induced
responses through its recognition of lipopolysaccharide
(LPS). Recognition of Gram-positive bacteria is primarily
mediated by TLR2, which recognizes an array of microbial
molecules in part by hetero-dimerization with other
TLRs (e.g. TLR1 and TLR6) or unrelated receptors (e.g.
Dectin-1) [13]. TLR activation triggers nuclear factor-kappa
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activated protein kinase signalling leading to altered gene
expression, including pro-inﬂammatory cytokine and IFN-
inducible genes [13]. TLRs are highly expressed on profes-
sionalphagocytes but also to some degree in other cell types
[14–16]. A full characterization of TLR expression and re-
sponsiveness to bacterial ligands in primary HPMC has not
been carried out previously to our knowledge. In the present
study, we have investigated the recognition of bacterial li-
gands by TLR family members in HPMC. Our data dem-
onstrate the expression of a speciﬁc subset of TLRs by
HPMC which enables the detection of both Gram-positive
and Gram-negative bacteria. These ﬁndings emphasize the
potentially important role the mesothelium plays in regulat-
ing local peritoneal host defense.
Materials and methods
Reagents
Pam3Cys and Pam2Cys were purchased from EMC Microcollections,
(Tu ¨bingen, Germany) and ultra-pure LPS (Escherichia coli O111:B4),
peptidoglycan and ﬂagellin (Salmonella typhimurium) from Invivogen
(San Diego, CA). Interleukin-1 beta (IL-1b) and tumour necrosis factor-
a were purchased from R&D Systems (Minneapolis, MN). A cell-free
supernatant from a clinical isolate of S. epidermidis (SES) was prepared
as described previously [17]. sCD14 was puriﬁed from human milk, as
described previously [18].
Isolation, culture and cell activation of HPMC
HPMC were isolated by tryptic digest of omental tissue from consenting
patients undergoing abdominal surgery and characterized as previously
described [8]. Prior to experimentation, HPMC monolayers were growth
arrested for 48 h in serum-free culture medium and stimulated for 24 h, as
indicated. Culture supernatants were harvested, rendered cell free by cen-
trifugation (300 g, 5 min) and stored at  80 C until use in commercially
available ELISA kits (BD Biosciences, Oxford, UK and R&D Systems).
Isolation of peripheral blood mononuclear cells
Peripheral blood mononuclear cells (PBMC) were isolated by Ficoll den-
sity-gradient centrifugation from whole blood of healthy volunteers and
adherence (2 h, 37 C). Cells were stimulated as indicated for 20 h in
phenol red-free RPMI 1640 medium (Invitrogen, Paisley, UK) with
0.5% human AB serum (TCS Biosciences, Buckingham, UK). For block-
ing experiments, the cells were preincubated with the anti-CD14-blocking
antibody (MY4; Beckman Coulter, High Wycombe, UK) for 1 h and the
stimulus was then added for the indicated time.
Culture and stimulation of transfected Human Embryonic Kidney Cells
Human embryonic kidney (HEK) 293 plasmid control-transfected cells
were cultured in complete medium: Dulbecco’s-modiﬁed Eagle’s medium
containing 4500 mg/mL glucose (Invitrogen) supplemented by 2 mM
L-glutamine and 10% fetal calf serum (FCS) and speciﬁc additives as
follows: 400 lg/mL hygromycin B (Calbiochem, San Diego, CA) for
HEK 293-TLR2 [19] or 200 lg/mL Geneticin (G418) (Sigma) for HEK
293-TLR4/MD2 (kindly provided by Prof. Douglas T. Golenbock, Uni-
versity of Massachusetts Medical School, North Worcester, MA, USA).
Cells were trypsinized and washed ﬁve times with phosphate-buffered
saline (PBS) to eliminate sCD14 before being stimulated as indicated.
Detection of TLR expression by immunocytochemistry
HPMC were ﬁxed on slides for 5 min in acetone at  20 C and left in PBS
overnight at 4 C. They were then blocked in PBS containing 1% (w/v)
bovine serum albumin (BSA) and 10% (v/v) normal rabbit serum for 1 h
before incubation with either an anti-TLR2-speciﬁc monoclonal antibody
(TLR2.5; eBioscience, San Diego, CA) or an isotype-matched mouse
monoclonal antibody (eBioscience) and then Alexa 568-conjugated Goat
anti-mouse IgG antibody (kindly provided by Prof. Valerie O’Donnell,
Cardiff University, Cardiff, UK).
Detection of TLR cell surface expression by ﬂow cytometry
HPMC were incubated with blocking buffer (50% ﬂow cytometry buffer:
PBS pH 7.3, 10 mM EDTA, 1% BSA, 15 mM sodium azide, 25% normal
rabbit serum (Dako, Glostrup, Denmark), 25% human AB serum) before
immunolabelling at 4 C with primary unconjugated antibodies directed
against human TLR1 (GD2.F4), TLR2 (2.1), TLR4 (HTA125), TLR6
(hPer6) and isotype-matched control antibodies (all eBioscience) and anti-
CA125 (Fujirebio Diagnostic, Malvern, PA) and appropriate goat anti-
mouse/rat phycoerythrin (PE)-conjugated secondary antibodies (Dako) or
PE-conjugatedanti-CD14(BD Biosciences)andanti-gp130(R&DSystems).
Up to 20 000 events were acquired using a FACSCalibur ﬂow cytometer
(BD Biosciences) using previously deﬁned settings for HPMC [20]a n d
speciﬁc primary antibody staining compared against the isotype control.
RNA isolation, reverse transcription–polymerase chain reaction and
real-time polymerase chain reaction
Total RNA was isolated from HPMC or murine peritoneal membrane using
Tri-Reagent (Sigma, Poole, UK) and following a chloroform–isopropanol
isolation protocol according to the manufacturer’s instructions. Before per-
forming reverse transcription–polymerase chain reaction (RT-PCRs),
messenger RNAs (mRNAs) were treated with RNAse-free DNAse I (Invi-
trogen) following the manufacturer’s instructions. Reverse transcription was
performed using 1 lg of RNA with the SuperScript II reverse transcriptase
(Invitrogen). PCR ampliﬁcation was performed with AmpliTaq Gold poly-
merase (Applied Biosystems, Warrington, UK; Table 1). For real-time PCR,
RNA was analysed with the NanoDrop-1000 spectrophotometer (Thermo
Fisher, Pittsburgh, PA). Reverse transcription was performed with 1 lg
RNA with the High Capacity complementary DNA (cDNA) Reverse Tran-
scription kit (for HPMC; Applied Biosystems) or SuperScript II reverse
transcriptase (forperitonealmembrane;Invitrogen) usingthemanufacturer’s
protocol. cDNA (diluted 1:5) was used to perform real-time PCR using
Power SYBR Green PCR master mix (Applied Biosystems) and standard
primers (Table 2; from Invitrogen) (for HPMC) or Taqman Universal PCR
master mix and primer probe sets (for murine peritoneal membrane, Eukar-
ytotic 18s RNA VIC-labelled, 4310893E and murine Tlr2, FAM-labelled
probe, Mm00442346_m1; all Applied Biosystems), using the manufac-
turer’s protocol and the following cycling conditions: (i) 1 cycle, 95 C1 0
min,(ii)40cycles,95 C15s ,60  C1min,(iii)1cycle,95 C15s,60  C1 5s ,
95 C 15 s, using an Applied Biosystems ABI 7900 HT machine. Baseline
and threshold for Ct values were determined using the Sequence Detection
System 2.3 software (Applied Biosystems). Results are expressed as relative
induction from the housekeeping gene Gapdh (HPMC) or 18s RNA (peri-
toneal membrane) (2
 DCt)o ru s i n gt h e2
 DDCt method [22].
NF-jB reporter assay
HEK-TLR2 or HEK-TLR4/MD2 cells (1 3 10
5 cells per well) were tran-
siently transfected (Lipofectamine transfection reagent; Invitrogen) with
0.25 lg of NF-jB-responsive ﬁreﬂy luciferase reporter (pNF-jB Luc;
Stratagene, La Jolla, CA) and 0.05 lg Renilla luciferase under control
of a constitutive SV40 promoter (pRL-SV40; Promega, Southampton,
UK). After 48 h, cells were stimulated for 16 h with SES concentrations
as indicated. Luciferase activity was measured using the Dual Luciferase
Reporter Assay (Promega).
Induction of acute peritoneal inﬂammation
Experiments wereperformedusing 8- to 12-week-old 129/C57BL6/Jmice,
according to Home Ofﬁce regulations (PPL:30/2269). Peritoneal inﬂam-
mation was induced via the intraperitoneal route with 500 lL SES and at
designated time points the peritoneal membrane was snap-frozen [6].
Statistical analysis
Data presented are expressed as means (  SEMs) and statistical analysis
was performed using a two-tailed Student’s t-test. A P-value of <0.05 was
considered signiﬁcantly different.
Results
HPMC express a distinct subset of TLRs
The major resident cell populations within the peritoneal
cavity, i.e. mesothelial cells, macrophages and lymphocytes,
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orchestrating leucocytes trafﬁcking [5 6 8 17 23].
While monocyte/macrophage TLR expression has been
well described [24], human mesothelial TLR expression
and responsiveness to bacterial ligands has not been char-
acterized. To investigate TLR expression (TLR1–TLR10)
by HPMC, we performed real-time PCR analysis and found
a range of relative expression ranging high expression
(TLRs 1–3), low/moderate levels (TLRs 4–6) to very
low/undetectable expression (TLRs 7–10) (Figure 1A). A
relative comparison with TLR mRNA expression in PBMC
revealed lower levels of all the TLRs in HPMC, except
TLR3 (Table 3).
To evaluate responses to Gram-positive bacteria and
Gram-negative bacteria, we further examined TLR2 and
TLR4 expression by reverse transcription–polymerase
chain reaction (RT-PCR) and ﬂow cytometry (Figure 1B
and C, respectively). We also measured TLR1 and TLR6
expression, which form heterodimers with TLR2 [13].
TLR2 and TLR6 mRNA expression were detected by
RT–PCR but only an indistinct product observed for
TLR4 (Figure 1B). TLR1 and TLR2 expression were de-
tected on the cell surface by ﬂow cytometry, but TLR4 and
TLR6 were undetectable on either growth-arrested or
stimulated HPMC (Figure 1C and data not shown). TLR2
expression was also consistently detected in HPMC
by immunohistochemistry (Figure 1D), despite variable
expression observed between different HPMC lines by
ﬂow cytometry (Figure 1E).
To eliminate the possibility that TLR4 downregulation
(also called ‘LPS tolerance’ [25]) might account for the lack
of TLR4 detected in cultured HPMC, we analyzed cells by
ﬂow cytometry, directly following their isolation (i.e. without
passage). As reported previously under these conditions,
HPMC displayed high-cell surface expression of CA125
[26] and gp130 [20]. TLR2 expression was also detectable,
but we were unable to detect TLR4 (Figure 1F).
HPMC respond to ligands for TLR2 and TLR5 but not TLR4
To characterize mesothelial cell responses to Gram-positive
and Gram-negative bacteria, we treated HPMC with
ligands to TLR2/1 (Pam3Cys), which does not mediate
local or systemic effects in TLR2-deﬁcient mice [27], and
TLR4 (LPS), plus a well-characterized cell-free superna-
tant derived from a clinical S. epidermidis isolate (SES),
previously used to investigate acute inﬂammatory regula-
tion in vivo [6,17]. Chemokine (CXCL8, CCL2 and CCL5)
and cytokine (IL-6) production were assessed. SES and
Pam3Cys induced a dose-dependent increase in CXCL8,
IL-6 and CCL2 (Figure 2A), whereas LPS had no effect,
even at extremely high doses (up to 5 lg/mL) (Figure 2A
and B). As previously mentioned, cells may lose respon-
siveness to LPS, but certain genes are resistant to this proc-
ess, e.g. the chemokine CCL5/RANTES [28]. However,
CCL5 levels were not increased by LPS stimulation
of HPMC at high or low concentrations (Figure 2B and
Supplementary Figure 1).
Stimulation with Pam2Cys (MALP-2 analogue, a
TLR2/6 ligand) also triggered a dose-dependent increase
i nC X C L 8s e c r e t i o nb yH P M C( Figure 2C), demon-
strating that the low TLR6 expression observed (Figures
Table 2. Primer sequence used for real-time PCR primer sequences were designed using Primer3 [21]
Human Tlr
Sequence (5#–3#)
Accession number Forward Reverse
Tlr1 CAATGCTGCTGTTCAGCTCTTC GCCCAATATGCCTTTGTTATCC NM_003263.3
Tlr2 AATCCTCCAATCAGGCTTCTCT TGTAGGTCACTGTTGCTAATGTAGGT NM_003264.3
Tlr3 GAAAGGCTAGCAGTCATCCAAC GTCAGCAACTTCATGGCTAACA NM_003265.2
Tlr4 AGAACCTGGACCTGAGCTTTAATC GAGGTGGCTTAGGCTCTGATATG NM_138554.2
Tlr5 ACAAGATTCATACTCCTGATGCTACTG CCAGGAAAGCTGGGCAACTA NM_003268.3
Tlr6 ATTGTTAAAAGCTTCCATTTTGTTTG CTAAGACTTTGGTTTTCAGCGGTAG NM_006068.2
Tlr7 TCTCATGCTCTGCTCTCTTCAAC TTGTCTCTTCAGTGTCCACATTGGAAA NM_016562.3
Tlr8 GCTTGACTTACGTGGAAACAAACTAC AACTTAAATCGAGGTGCTTCAGACTAC NM_016610.2
Tlr9 TATTCATGGACGGCAACTGTTATT TACTTGAGTGACAGGTGGGTGAG NM_017442.2
Tlr10 CGATTCCACGCATTTATTTCATAC TAGCTTTCATAAAGGCAAATCAAGATAG NM_001017388.1
Gapdh CCTCTGACTTCAACAGCGACAC TGTCATACCAGGAAATGAGCTTGA NM_002046.3
Table 1. Primer sequence and protocol used for RT-PCR
Primer
Sequence (5#–3#)
Forward Reverse
Tlr2 TGGCCAGCAGGTTCAGGATG TCGCAGCTCTCAGATTTACCC
Tlr4 CCTCCAGGTTCTTGATTACAG GTGCCGCCCCAGGACACT
Tlr6 AGAACTCACCAGAGGTCCAACC GAAGGCATATCCTTCGTCATGAG
Actin CGGCCAGCCAGGTCCAGA GTGGGCATGGGTCAGAAGGATT
PCR ampliﬁcation 32 cycles (TLR2 and TLR4) or 22 cycles (actin) at 94 C for 40 s, 56 C for 40 s and 72 C for 90 s
Toll-like receptors in human mesothelial cells 40811A–C) is sufﬁcient to allow responses to Pam2Cys. In-
deed, the relatively low TLR1 and TLR2 expression de-
tected by ﬂow cytometry nevertheless allowed responses
to TLR2/1 ligands, e.g. Pam3Cys or peptidoglycan (data
not shown). HPMC did not respond to zymosan, another
TLR2/6 ligand (data not shown), potentially due to a
lack of Dectin-1 expression, the coreceptor for zymozan
[29].
Fig. 1. Analysis of TLR expression by primary HPMC. (A) Analysis of TLR1-TLR10 mRNA expression in HPMC was performed by real-time PCR.
Speciﬁc primers were used to amplify human TLR1-TLR10 cDNAs prepared from total RNA from unstimulated HPMC. Expression of each mRNA was
determined by the calculation of 2
 DCt as described in the Methods section and was expressed relative to the expression of glyceraldehyde 3-phosphate
dehydrogenase (GAPDH). (B) Expression of mRNA for TLR2, TLR4, TLR6 and b-actin was assessed by RT-PCR using speciﬁc primer pairs in
unstimulated HPMC and analyzed by agarose gel electrophoresis. (C) Cell surface expression of TLR2,TLR4 and TLR6 was assessed by ﬂow cytometry
usingspeciﬁcantibodies(openplots).Controlproﬁlescorrespondingtotheimmunostainingwithisotypecontrolantibodiesarealsoshown(shadedplots).
Theseresultsarerepresentativeofsevendifferentcelllinesfromindividualdonors.HumanPBMCwereusedasapositivecontrolfortheTLR4andTLR6
antibodies. (D) Unstimulated HPMC were assessed for TLR2 expression by immunocytochemistry using the TLR2.5 monoclonal antibody. A gp130
antibodywasusedasapositivecontrolandcontrolantibodieswereusedasnegativecontrolsforbothTLR2andgp130staining.Resultsarerepresentativeof
immunostaining of two differentprimary cell lines.(E) Primary HPMCoriginatingfrom different donorswere stained with TLR2.1monoclonal antibody
andanalyzedbyﬂowcytometry.Thenegativecontrolstainingfromtheisotypecontrolantibodyisshadedingrayandisidenticalforalldonors.Theresults
shownwereobtainedfromfourprimarycelllines.(F)Mesothelialcellswereanalyzedforcellsurfacemarkerexpressiondirectlyfollowingtrypticdigestsof
omental tissue. Cells were stained with antibodies speciﬁc for gp130, CA125, TLR2 and TLR4 and cell surface expression detected by ﬂow cytometry.
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Gram-positive bacterial ligands, they were unable to re-
spond to the TLR4 agonist, LPS (Figure 2A and B).
Real-time PCR data, however, suggested a low TLR5 ex-
pression (Figure 1A), which detects a ﬂagellum component
(ﬂagellin), commonly found on many Gram-negative bac-
teria [30] We stimulated HPMC with increasing doses of
ﬂagellin and observed a dose-dependent increase in
CXCL8 (Figure 2D), implying that direct responses to
Gram-negative bacteria in HPMC may occur through
TLR5 not TLR4. The results obtained in Figure 2A–C
regarding HPMC response to LPS, Pam3Cys, Pam2Cys,
and SES were conﬁrmed by measurement of NF-jB activa-
tion by electrophoretic mobility shift assay (Supplementary
Figure 2).
CD14 is not required for a coreceptor for TLR2-
mediated responses in HPMC
We determined that the clinically relevant stimulus, SES,
speciﬁcally activated responses through TLR2, which
would be present on peritoneal mesothelial cells and resi-
dent peritoneal leucocytes and not via TLR4 (present on
resident leucocytes only) (Figure 3). These experiments
were carried out using stably transfected HEK293 cells
expressing high levels of TLR2 or TLR4 and its co-factor
MD2 (HEK-TLR2 and HEK-TLR4/MD2, respectively,
Figure 3A) and plasmid control-transfected cells (HEK-
pDR2). TLR2, but not TLR4 or control cells, responded
to SES stimulation in a dose-dependent manner either
through increased CXCL8 production or through NF-jB
reporter activity (Figure 3B–D), demonstrating that TLR2,
but not TLR4, is required for SES-mediated responses. SES
may activate other pattern recognition pathways, notably
the nucleotide-binding oligomerization domain(NOD)-like
receptors (NLRs), NOD1 and NOD2. NOD1 and NOD2
recognize dipeptides derived from bacterial peptidoglycan
(NOD1:Gram-negativeandspeciﬁcGram-positivebacteria,
not including Staphylococcus species; NOD2: all Gram-
negative and Gram-positive bacteria) [31, 32]. An analysis
of HPMC responses to NOD1- and NOD2-speciﬁc agonists
[gamma-D-glutamyl-meso-diaminopimelic acid/ (eE-DAP)
and muramyl dipeptide/MDP, respectively] revealed a mod-
est induction of CXCL8 in response to iE-DAP and no
induction in response to MDP (data not shown). These re-
sults are similar to the ﬁndings of Park et al. [7]i nm u r i n e
mesothelial cells, which identiﬁed responses to NOD1, but
not NOD2.
To test whether CD14 was required for TLR2-mediated
responses triggered by SES in HPMC, we analysed the
cell surface expression of CD14 by ﬂow cytometry. No cell
surface expression of CD14 was detected in HPMC
regardless of serum, unlike PBMC, which expressed high
levels of cell surface CD14 (Figure 4A). To investigate
whether low levels of CD14, potentially below the limit
of detection by ﬂow cytometry, were capable of enhancing
TLR2-mediated responses, we performed experiments us-
ing an anti-CD14-blocking antibody. The anti-CD14-
blocking antibody had no effect on SES-induced CXCL8
in HPMC (Figure 4B), while it signiﬁcantly reduced
CXCL8 production induced by both SES and LPS in
PBMC (Figure 4C). This ﬁnding implies that if TLR2 re-
quires CD14 for efﬁcient signalling, it has to be provided in
its soluble form. We therefore measured CXCL8 produc-
tion in HPMC treated with Pam3Cys and SES with or with-
out serum, as a source of sCD14. Pam3Cys and SES
triggered a signiﬁcantly higher response in the presence
of serum (Figure 4D and E). To investigate the potential
of sCD14 speciﬁcally to enhance responses to SES stimu-
lation, we stimulated HPMC in the presence or absence of
sCD14. As shown in Figure 4F, SES-induced CXCL8
secretion was not altered by sCD14. Therefore, our results
suggest that CD14 is required for SES-mediated responses
in PBMC, but not in HPMC.
Modulation of TLR2 expression by inﬂammatory
cytokines and TLR ligands
TLR2expressioncanbemodulatedfollowingactivationwith
cytokinesandmicrobialligands[33,34].Inordertostudythe
regulation of TLR2 expression, we examined TLR2 mRNA
expression in HPMC by real-time PCR following treatment
with cytokines and TLR ligands. We observed that TLR2
mRNAexpressionwasup-regulatedupon3hpoststimulation
Table 3. Relative TLR expression in HPMC
a
Tlr gene
Tlr (2
 DCt)
Relative expression to PBMC HPMC PBMC
Tlr1 0.0041 0.0547 0.0749
Tlr2 0.0134 0.2943 0.0455
Tlr3 0.0089 0.0010 8.9
Tlr4 0.0018 0.0330 0.0545
Tlr5 0.0003 0.0033 0.0909
Tlr6 0.0012 0.0351 0.0342
Tlr7 2.13 3 10
 5 0.0022 0.0097
Tlr8 2.37 3 10
 6 0.0540 4.39 3 10
 5
Tlr9 4.55 3 10
 5 0.0029 0.0157
Tlr10 7.96 3 10
 6 0.0037 0.0022
aWe evaluated by quantitative PCR the expression of TLR1 to TLR10 in HPMC (as shown in Figure 1A) as well as in PBMC, known to express most
TLRs. Results are expressed as the ratio of the Tlr gene (2
 DCt) to the housekeeping gene glyceraldehyde 3-phosphate dehydrogenase (2
 DCt) for each
cell type as described in the Methods section and then as the relative difference in expression between HPMC and PBMC (HPMC/PBMC).
Toll-like receptors in human mesothelial cells 4083withIL-1borPam3Cys(Figure5A),aspreviouslydescribedin
epithelial cell lines [35] and murine pleural mesothelial cells
[36]. This TLR2 up-regulation by Pam3Cys was conﬁrmed by
immunocytochemistry (Figure 5B), using a protocol validated
using HEK-TLR2 transfectants (Supplementary Figure 3).
TLR1 and TLR6 mRNA expression did not change from
Fig. 2. Response of HPMC to bacterial TLR agonists. (A) HPMC were stimulated with serial dilutions of SES (1/200-Neat) Pam3Cys (0.1–20 lg/mL) or
LPS (2–500 ng/mL). After 24-h incubation CXCL8, IL-6 or CCL2 levels were quantiﬁed in cell-free supernatants using ELISA. Data shown are a result
representative of at least three experiments performed using primary cell lines from different donors (*P < 0.05; **P < 0.01 between unstimulated and
stimulated cells with the indicated ligands). (B) HPMC were stimulated with high doses of LPS (1–5 lg/mL). After 24-h incubation, CXCL8 and CCL5
levels were quantiﬁed in cell-free supernatants using ELISA (***P < 0.001). (C) HPMC were stimulated for 24 h with increasing doses of Pam2Cys
(MALP-2 analogue) or neat SES (with 0.1% FCS) and CXCL8 levels were quantiﬁed by ELISA in cell-free supernatants. Data presented are results
representative of four independent experiments (**P < 0.01; P < 0.001 between unstimulated and stimulated cells with Pam2Cys. (D) HPMC were
stimulated for 24 h with increasing doses of ﬂagellin and CXCL8 levels were quantiﬁed by ELISA in cell-free supernatants. Data presented are results
representative of two independent experiments (*P < 0.05 between unstimulated and stimulated cells with ﬂagellin).
4084 C.S. Colmont et al.basallevelsfollowingstimulationwiththesamestimuli(data
not shown).
The IFN-c and TLR signalling pathways are important
regulators of macrophage function [37]a n dI F N - c up-
regulates several TLR family mRNAs, in particular
TLR2 [33, 34]. Given the crucial role played by IFN-c
in regulating peritoneal immune responses [6, 38], TLR2
expression was analysed by real-time PCR following
stimulation of HPMC with IFN-c. Over a 24-h period,
we showed a 7-fold increase of TLR2 expression peak-
i n ga t6ha n dr e t u r n i n gt ob a s e l i n el e v e l sb y1 2h( Figure
5C). We also observed a similar pattern of TLR2 expres-
sion following stimulation with SES with an earlier peak
at 3 h (Figure 5C). To complement these in vitro obser-
vations, we used our well-established in vivo model of
peritoneal inﬂammation to examine TLR mRNA expres-
sion during SES-induced activation [6, 17]. Real-time
PCR was performed using RNA extracted from the
Fig. 3. Responses to SES are mediated by TLR2 but not TLR4. (A) Proﬁle of TLR2 expression in HEK-TLR2 cell transfectants (left) was obtained by staining
withPE-conjugatedanti-TLR2,TL2.1oranisotype-matchedcontrolantibodies.ProﬁleofTLR4expressioninHEK-TLR4celltransfectants(right)wasobtained
by staining with the unconjugated anti-TLR4 monoclonal antibody, HTA125 or an isotype-matched control IgG, followed by incubation with a secondary PE-
conjugatedanti-mouseantibody.Immunostainedcellswereanalysedbyﬂowcytometry.(B)HEK293cellsstablytransfectedwithanemptyplasmidvector(HEK-
pDR2) or TLR2 expression vector (HEK-TLR2) were stimulated for 15 h with increasing concentration of SES in the presence or absence of 1% FCS. CXCL8
levelswerequantiﬁedincell-freeculturesupernatantsbyELISA.Datapresentedarearepresentativeresultofthreeexperimentsperformedintriplicate(*P<0.05;
**P < 0.01; ***P < 0.001 between HEK-pDR2 and HEK-TLR2 stimulated in the absence of serum and between HEK-TLR2 stimulated in the presence or
absence of 1% FCS). (C) HEK-TLR2 or HEK-TLR4/MD2 cells were transiently transfected with an NF-jB luciferase Fireﬂy reporter and constitutive Renilla
luciferase vectors and following 48 h in culture stimulated with SES (1/100 dilution to Neat) for 16 h. Dual luciferase activity was then assayed and theF i r e ﬂ y
reporterresultsnormalizedagainsttheRenillasignalobtainedasthefoldchangeabovethecontrol.(D)HEK-TLR4/MD2cellsweretransientlytransfectedwithan
NF-jB-responsiveFireﬂyluciferasereporterandconstitutiveRenillaluciferasevectorsandfollowing48hinculturestimulatedwithLPS(0–100ng/mL),sCD14
andLBP(0.5lg/mLand0.1lg/mL,respectively)for16h.DualluciferaseactivitywasthenassayedandtheFireﬂyreporterresultsnormalizedagainsttheRenilla
signal obtained as the fold change above the control.
Toll-like receptors in human mesothelial cells 4085parietal peritoneal membrane at various time points fol-
lowing SES injection. This analysis showed a rapid and
transient 3-fold increase of TLR2 mRNA expression
(Figure 5D). This peak in TLR2 expression coincides
with the time point of peak chemokine expression
(CXCL1/KC and CXCL2/MIP-2) [6, 17].
Discussion
Repeated peritonitis is a feature of PD treatment and pre-
dominantly caused by Gram-positive bacteria, especially
Staphylococcus species [2]. However, Gram-negative bac-
terial infections also represent a signiﬁcant problem
and overall have a worse prognosis in terms of patient
outcomes [3]. It is a generally thought that host defenses
are compromised in PD patients as a result of dialysis
solution exposure, dilution of humoral factors and alter-
ation in resident and recruited leucocytes function [4,
39]. The initial peritoneal immune response involves
contributions not only from resident peritoneal leuco-
cytes [23, 40] but also from the peritoneal mesothelial
cells, lining the parietal and visceral peritoneum [41].
Mesothelial cells express adhesion molecules [42], syn-
thesize cytokines and chemokines [6, 8, 17]a n dp r e s e n t
antigen via major histocompatibility complex Class II,
promoting CD4
1 T-cell responses [11, 43, 44]. There-
fore, we examined TLR expression by HPMC and char-
acterized their responses to bacterial agonists. To our
knowledge, this study represents the most comprehen-
sive characterization of TLR expression and responsive-
ness to bacterial ligands in primary HPMC to date.
An analysis of TLR expression by HPMC identiﬁed
expression of a restricted subset of TLR family members
(TLR1-6), which was in agreement with ﬁndings from mur-
ine peritoneal mesothelial cells [7, 45]. However, experi-
ments examining the responsiveness of HPMC to bacterial
TLR agonists revealed important differences between
human and murine systems. Although HPMC responded
to TLR1/2, TLR2/6 and TLR5 ligands in a similar manner
to murine cells, human cells, unlike reports from murine
cells, were unresponsive to the TLR4 agonist LPS [7, 45].
As in our previous studies, we went to great lengths (using
differential subculture) to ensure that HPMC cultures were
not contaminated with peritoneal ﬁbroblasts or residual
resident macrophages that might contribute to apparent
TLR4 expression [8, 46–48].
Lack of TLR4 responsiveness may also be due to TLR4
downregulation at the cell surface, known as ‘LPS toler-
ance’ [25]. Analysis of freshly isolated mesothelial cells
and quantiﬁcation of the tolerization-resistant chemokine
CCL5 appeared to exclude tolerance for the lack of TLR4
responsiveness [28]. Poor responses to TLR4 ligands in
airway smooth muscle cells were overcome by co-culture
with PBMC in an IL-1b-dependent manner [49]. Therefore,
peritoneal macrophages may act as important sensors of
Gram-negative bacterial infections, indirectly activating
mesothelial cells [4, 39, 50]. Alternatively, mesothelial
LPS hypo-responsiveness may be beneﬁcial in avoiding
excessive inﬂammation. In this respect, intestinal epithelial
cells lose their ability to respond to LPS after birth [51].
Overall, our data suggest that HPMC respond to bacterial
infections through TLR2 (Gram-positive bacteria) and
TLR5 (ﬂagellated bacteria, predominantly Gram negative)
and thatof othersto viral pathogens via TLR3 recognition of
double-stranded RNA [52]. These data do not exclude the
possibility that other pattern recognition receptor families,
e.g. NOD-like receptors NLRs and retinoic acid-inducible
gene-I-like receptors (RLRs), may also play a role in patho-
gen recognition in HPMC [32].
TLR5 mediates recognition of ﬂagellin, a ﬂagellum com-
ponent, present on many motile bacteria [28]. Interestingly,
TLR5 expression in the intestinal epithelium is limited to
the basolateral surface and is activated upon bacterial in-
vasion of the gut wall [53, 54]. TLR5-deﬁcient mice de-
velop a TLR4-dependent spontaneous colitis, suggesting a
critical role for TLR5 in maintaining the host-microﬂora
balance within the gastro-intestinal tract [55]. TLR5 ex-
pression on mesothelial cells may therefore be critical in
sensing invasion of ﬂagellated bacteria into the peritoneal
cavity. Translocation of intestinal bacteria is a potential
cause of infection in PD patients, along with access through
the intraperitoneal catheter[3], and many ﬂagellated bacte-
ria are Gram-negative species, with a poor outcome in PD-
associated peritonitis [2].
TLR2, but not TLR4, expression was critical for the rec-
ognition of a S. epidermidis-derived cell free supernatant
(SES), which has been extensively utilized to model acute
peritoneal inﬂammation [16, 17]. Similarly, others have
demonstrated that TLR2 is required for cellular responses
to and clearance of Staphylococcus species [56, 58].
TLR2 may also act in concert with co-receptors e.g. other
TLRs(TLR1/6),Dectin-1,CD36orCD14,aco-factorfor
both TLR2- and TLR4-mediated responses [13, 59].
CD14 blockade signiﬁcantly reduced SES-induced re-
sponses in PBMC indicating that, in leucocytes, TLR-
mediated responses are highly CD14 dependent. HPMC
lacked cell surface expression of CD14, and although
serum, a source of soluble CD14, had a signiﬁcant effect
on SES-mediated response in HPMC, puriﬁed sCD14 did
not. These results indicate that (i) the requirement for
CD14 in TLR2 activation is cell speciﬁc and (ii) there
may be other soluble co-factors in serum that co-operate
with TLR2 signalling.
Finally, we identiﬁed the up-regulation of TLR2
expression in response to both TLR2-speciﬁc agonists
and pro-inﬂammatory cytokines in HPMC and in
response to SES in vivo. It is well established in other cell
types that both TLR and cytokine signalling may inﬂu-
ence TLR expression and responsiveness [33–36, 60]. In
particular, van Aubel et al. [60] described a differential
cross-talk between TLRs 2, 4 and 5, and TLR4-induced
IFN-c production led to a sensitization of TLR2-depend-
ent activation in a model of Gram-negative sepsis [61].
Interestingly, the induction of TLR2 expression in vivo
coincides with the peak of neutrophil-attracting chemo-
kine expression [6, 17, 62], suggesting the involvement of
TLR2 in these critical early immune activation events.
Mesothelial cells are a major resident cell type within
the peritoneal cavity and are therefore likely to encounter
infecting bacteria, triggering local inﬂammation and
host defence [50]. This study is the ﬁrst to fully
4086 C.S. Colmont et al.Fig.4. CD14canactasaco-receptorforSES.(A)HPMCwereimmunostainedwithaPE-conjugatedCD14monoclonalantibodyinthepresenceorabsence
of 10% serum and human PBMC were used as a positive control for CD14 expression (isotype control antibody shaded in gray and CD14 expression
outlined in black). Data presented are a representative result of six experiments performed with primary cell lines derived from separate donors. (B) HPMC
were stimulated in medium with SES (1/10 dilution) in the presence or absence of anti-CD14-blocking antibody (10 lg/mL) for 1 h 30 min. CXCL8 levels
werequantiﬁedincell-freeculturesupernatantsbyELISA.DatapresentedarerepresentativeofthreeexperimentsperformedintriplicatewithHPMCderived
from three independent donors. (C) PBMC were isolated from healthy human volunteers and were stimulated in medium containing 0.5% human AB serum
withLPS(50ng/mL)orSES(1/80dilution)inthe presenceorabsence ofanti-CD14-blockingantibody(10lg/mL)for1h.CXCL8levelswerequantiﬁedin
cell-free culture supernatants by ELISA. Data presented are representative of three experiments performed in triplicate with PBMC derived from three
independent donors (**P < 0.01). (D) HPMC were stimulated with Pam3Cys (2 lg/mL) in the presence or absence of 0.1% FCS (as a source of sCD14) for
24 h.CXCL8levelswerequantiﬁedincell-free culturesupernatants byELISA.Data presentedarerepresentativeofthree experimentsperformedintriplicate
with primary cell lines derived from three independent donors (*P < 0.05). (E) HPMC were stimulated with SES (Neat) in the presence or absence of 0.1%
FCS (as a source of sCD14) for 24 h. CXCL8 levels were quantiﬁed in cell-free culture supernatants by ELISA. Data presented are representative of three
experiments performed in triplicate with primary cell lines derived from three independent donors (*P < 0.05). (F) HPMC were stimulated with increasing
doses of SES in medium without serum in the absence or presence of sCD14 (500 ng/mL) for 24 h. CXCL8 levels were quantiﬁed in cell-free culture
supernatants by ELISA. Data presented are representative of three experiments performed in triplicate with HPMC derived from three independent donors.
(*P < 0.05 between unstimulated cells and the indicated doses of SES).
Toll-like receptors in human mesothelial cells 4087characterize HPMC expression of TLRs and their re-
sponses to bacterial ligands. An understanding of TLR-
mediated responses during peritonitis will be important in
improving compromised host defense in PD patients,
reducing infection and improving clinical outcome.
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Supplementary data are available online at http://
ndt.oxfordjournals.org.
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